Ring Christine

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 19. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 19
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Nurix Therapeutics, Inc.Chief Legal OfficerOption exercisenothing paid5,787 sharesSep 2, 2026Nurix Therapeutics, Inc.Chief Legal Officernothing paidExercise · Sep 2Option exercise5,787Sep 2, 2026
Nurix Therapeutics, Inc.Chief Legal OfficerOpen-market sell$10,655400 sharesSep 2, 2026Nurix Therapeutics, Inc.Chief Legal Officer$10,655Sell · Sep 2Open-market sell400Sep 2, 2026
Nurix Therapeutics, Inc.Chief Legal OfficerOpen-market sell$138,4175,387 sharesSep 2, 2026Nurix Therapeutics, Inc.Chief Legal Officer$138,417Sell · Sep 2Open-market sell5,387Sep 2, 2026
Nurix Therapeutics, Inc.Chief Legal OfficerOption exercise$50,4635,787 sharesSep 2, 2026Nurix Therapeutics, Inc.Chief Legal Officer$50,463Exercise · Sep 2Option exercise5,787Sep 2, 2026
Nurix Therapeutics, Inc.Chief Legal OfficerOption exercisenothing paid5,787 sharesAug 3, 2026Nurix Therapeutics, Inc.Chief Legal Officernothing paidExercise · Aug 3Option exercise5,787Aug 3, 2026